The distribution of necrosis during treatment (Fig 3) shows that Eμ-myc/p53-/- cells in the tumor periphery (Sets S1 and S5, gray bars) were relatively unaffected by the drug, with most of the death occurring in the center of the tumor (Set S3, gray bars). Here, TP53 is linked to neoplasm.